Life and Death Decision-Making by p53 and Implications for Cancer Immunotherapy.

Trends in Cancer
Yong LiuYanping Zhang

Abstract

The tumor-suppressor protein p53 is mutated in approximately half of all cancers, whereas the p53 signaling network is perturbed in almost all cancers. In response to different stress stimuli, p53 selectively activates genes to elicit a cell survival or cell death response. How p53 makes the decision between life and death remains a fascinating question and an exciting field of research. Understanding how this decision is made has major implications for improving cancer treatments, particularly in recently evolved immune checkpoint inhibition therapy. We highlight progress and challenges in understanding the mechanisms governing the p53 life and death decision-making process, and discuss how this decision is relevant to immune system regulation. Finally, we discuss how knowledge of the p53 pro-survival and pro-death decision node can be applied to optimize immune checkpoint inhibitor therapy for cancer treatment.

References

May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·P ShawJ Costa
Jul 5, 1991·Science·M HollsteinC C Harris
Jun 1, 1995·Molecular and Cellular Biology·L B Owen-SchaubE Kruzel
Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
Apr 21, 2001·Molecular and Cellular Biology·S T SzakJ A Pietenpol
Dec 12, 2001·Nature Cell Biology·Thomas G HofmannM Lienhard Schmitz
Apr 24, 2002·Immunity·Jesus M SalvadorAlbert J Fornace
Dec 10, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sohail ChaudhryKevin Gardner
Jan 20, 2004·Nature Genetics·Galit LahavUri Alon
Sep 15, 2004·The Journal of Cell Biology·M BenteleR Eils
Apr 14, 2005·Journal of Molecular Biology·Richard L WeinbergAlan R Fersht
May 24, 2006·The Journal of Cell Biology·Chad D KnightsMaria Laura Avantaggiati
Dec 26, 2006·Molecular Cell·Stephen M SykesSteven B McMahon
Jun 2, 2007·Molecular Cell·Tsung-Cheng ChangJoshua T Mendell
Aug 31, 2007·Oncogene·Cesar Munoz-FontelaCarmen Rivas
Jul 30, 2008·The Journal of Experimental Medicine·César Muñoz-FontelaStuart A Aaronson
Nov 18, 2008·Nature Cell Biology·Martin JanssonNicholas B La Thangue
Jan 16, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ho-Chou TuEmily H-Y Cheng
May 12, 2009·Immunological Reviews·James L Riley
Jul 25, 2009·Nature·Hiroshi I SuzukiKohei Miyazono
Mar 24, 2010·Proceedings of the National Academy of Sciences of the United States of America·Munekazu YamakuchiCharles J Lowenstein
Feb 1, 2011·Journal of Molecular Cell Biology·Zhaohui FengWenwei Hu
Mar 19, 2011·Cell·Sabrina L Spencer, Peter K Sorger
May 15, 2012·Molecular Oncology·Claudia PiovanCarlo M Croce
Jun 16, 2012·Science·Jeremy E PurvisGalit Lahav
Aug 18, 2012·Nature Reviews. Cancer·Heiko Hermeking
Nov 20, 2012·Annual Review of Immunology·Guido KroemerLaurence Zitvogel
Nov 21, 2012·Cell Cycle·Harsha S MadapuraNoémi Nagy
Jan 12, 2013·Cell Death and Differentiation·M KracikovaS A Aaronson
May 18, 2013·Nature Reviews. Immunology·Luke A J O'NeillAndrew G Bowie
Jul 16, 2013·Journal of the National Cancer Institute·Patrizia LeoneVito Racanelli

❮ Previous
Next ❯

Citations

May 15, 2021·Journal of Evidence-based Medicine·Dehua YuJiangjiang Qin
Aug 6, 2021·Biology Direct·Eleonora MammarellaIvano Amelio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.